| 臺大學術典藏 |
2020-12-04T07:44:28Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Qian Y.; Zhao Z.; Rane P.P.; Hsiao F.-Y.; Chen W.-J.; Wen Y.-C.; Fox K.M.; Shen L.-J.; LIAN-YU LIN |
| 臺北醫學大學 |
2014 |
Treatment plan comparison between stereotactic body radiation therapy techniques for prostate cancer: Non-isocentric CyberKnife versus isocentric RapidArc
|
Lin, Yu-Wei;Lin, Kuei-Hua;Ho, Hsiu-Wen;Lin, Hsiu-Man;Lin, Li-Ching;Lee, Steve P.;Chui, Chen-Shou |
| 國立高雄師範大學 |
2002 |
Treatment program planning by speech therapists in Taiwan
|
曾進興; Chin-Hsing Tseng;W. Y. Chang |
| 國立臺灣大學 |
2008 |
Treatment Recommendations of Hospital-Acquired Pneumonia in Asian Countries: First Consensus Report by the Asian Hap Working Group
|
薛博仁; HSUEH, PO-REN |
| 國立成功大學 |
2012-01 |
Treatment response and cognitive impairment in major depression: Association with C-reactive protein
|
Chang, Hui Hua; Lee, I. Hui; Gean, Po Wu; Lee, Sheng-Yu; Chi, Mei Hung; Yang, Yen Kuang; Lu, Ru-Band; Chen, Po See |
| 高雄醫學大學 |
2010 |
Treatment response in Asian HCV: Different to the West
|
余明隆 |
| 臺大學術典藏 |
2020-10-22T07:27:42Z |
Treatment response in patients with moderate-to-severe psoriasis who had inadequate response to prior secukinumab
|
TSEN-FANG TSAI; Chiu T.-S. |
| 臺大學術典藏 |
2021-10-28T07:11:18Z |
Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab
|
Chiang C.-Y.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2021-01-06T08:23:27Z |
Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes
|
Su Y.;Yao-Hsu Yang;Chiang B.-L.; Su Y.; YAO-HSU YANG; Chiang B.-L. |
| 臺大學術典藏 |
2021-07-02T03:41:22Z |
Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes
|
Su Y.; Yang Y.-H.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2018-09-10T18:06:52Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai, M.-S. and Chang, S.-Y. and Lin, S.-W. and Kuo, C.-H. and Sun, H.-Y. and Wu, B.-R. and Tang, S.-Y. and Liu, W.-C. and Su, Y.-C. and Hung, C.-C. and Chang, S.-C.; CHING-HUA KUO; SHAN-CHWEN CHANG; HSIN-YUN SUN |
| 臺大學術典藏 |
2020-03-09T06:08:10Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.;Chang S.-Y.;Shu-Wen Lin;Kuo C.-H.;Sun H.-Y.;Wu B.-R.;Tang S.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Chang S.-C.; Tsai M.-S.; Chang S.-Y.; SHU-WEN LIN; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:25:54Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.;Sui-Yuan Chang;Lin S.-W.;Kuo C.-H.;Sun H.-Y.;Wu B.-R.;Tang S.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Chang S.-C.; Tsai M.-S.; SUI-YUAN CHANG; Lin S.-W.; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:26Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG; Chang S.-C.; Tsai M.-S.; Chang S.-Y.; Lin S.-W.; Kuo C.-H.; Sun H.-Y. |
| 臺大學術典藏 |
2017 |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Wu B.-R.; Tang S.-Y.; HSIN-YUN SUN; Kuo C.-H.; Lin S.-W.; Chang S.-Y.; Tsai M.-S.; Chang S.-C.; Hung C.-C.; Liu W.-C.; Su Y.-C. |
| 臺大學術典藏 |
2020-12-30T02:44:13Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.;Chang S.-Y.;Lin S.-W.;Kuo C.-H.;Sun H.-Y.;Wu B.-R.;Tang S.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Shan-Chwen Chang; Tsai M.-S.; Chang S.-Y.; Lin S.-W.; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-06-04T06:23:11Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.; Chang S.-Y.; Lin S.-W.; CHING-HUA KUO; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:18Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.; Chang S.-Y.; SHU-WEN LIN; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 國立成功大學 |
2024 |
Treatment Responses to Integrase Strand-transfer Inhibitor-containing Antiretroviral Regimens in Combination with Short-course Rifapentine-based Regimens for Latent Tuberculosis Infection among People with HIV
|
Lin;K, -Y.;Sun;H, -Y.;Yang;C, -J.;Lu;P, -L.;Lee;Y, -T.;Lee;N, -Y.;Liou;B, -H.;Tang;H, -J.;Lee;M, -H.;Wang;N, -C.;Chen;T, -C.;Hii;I, -M.;Huang;S, -H.;Lin;C, -Y.;Tsai;C, -S.;Cheng;C, -Y.;Hung;C, -C.;Chang;S, -Y.;Huang;Y, -S.;Chen;G, -J.;Wu;P, -Y.;Chen;L, -Y.;Chang;H, -Y.;Liu;W, -C.;Su;Y, -C.;Lin;T, -Y.;Tsai;M, -S.;Lee;Y, -C.;Cheng;S, -H.;Huang;Y, -C.;Peng;A, -T.;Lee;Y, -L.;Lin;C, -C.;Lin;S, -P.;Hsieh;C, -Y.;Wang;H, -W.;Ho;M, -W.;Liu;C, -E.;Hung;T, -C.;Chen;Y, -H.;Lee;C, -Y.;Tsai;H, -C.;Lin;H, -H.;Lee;C, -H. |
| 國立成功大學 |
2024-05-15 |
Treatment Responses to Integrase Strand-transfer Inhibitor-containing Antiretroviral Regimens in Combination With Short-course Rifapentine-based Regimens for Latent Tuberculosis Infection Among People With Human Immunodeficiency Virus
|
Lin;Kuan-Yin;Sun;Hsin-Yun;Yang;Chia-Jui;Lu;Po-Liang;Lee;Yuan-Ti;Lee;Nan-Yao;Liou;Bo-Huang;Tang;Hung-Jen;Lee;Mei-Hui;Wang;Ning-Chi;Chen;Tun-Chieh;Hii;Ing-Moi;Huang;Sung-Hsi;Lin;Chi-Ying;Tsai;Chin-Shiang;Cheng;Chien-Yu;Hung;Chien-Ching;Hung;Chien-Ching |
| 高雄醫學大學 |
2008 |
Treatment results for children with acute myeloid leukemia inTaiwan
|
梁德成;張泰琮;TPOG團隊 |
| 國立臺灣大學 |
1999 |
Treatment Results of Carcinoma of the Nasal Cavity
|
許智捷; 鍾娜娜; 雷德; 丁禮莉; HSU, CHIH-CHIECH; CHUNG, NA-NA; LUI, LOUIS TAK; TING, LAI-LEI |
| 中國醫藥大學 |
2007-07 |
Treatment Results of Hypopharyngeal Cancer Based on Definitive Radiotherapy
|
陳邦瑜(Pang-Yu Chen); 楊世能(Shih-Neng Yang); 梁基安(Ji-An Liang); 蔡銘修(Ming-Hsui Tsai); 陳尚文(Shang-Wen Chen)*; 林芳仁 |
| 中國醫藥大學 |
2007-07 |
Treatment Results of Hypopharyngeal Cancer Based on Definitive Radiotherapy
|
陳邦瑜(Pang-Yu Chen); 楊世能(Shih-Neng Yang); 梁基安(Ji-An Liang); 蔡銘修(Ming-Hsui Tsai); 陳尚文(Shang-Wen Chen)*; 林芳仁 |
| 國立臺灣大學 |
2000 |
Treatment Results of the Tpog-Nhl92 Protocols for Childhood Non-Hodgkin's Lymphomas in Taiwan: A Report from the Taiwan Pediatric Oncology Group ( Tpog)
|
盧孟佑; LU, MENG-YAO |
